The Food Safety and Standards Authority of India (FSSAI) has recently issued an advisory prohibiting the use of ashwagandha leaves in food products, supplements, and nutraceuticals, effective from April 2026. This directive clarifies that only the root and its extracts are approved for consumption, following reports of manufacturers using leaf extracts that do not meet safety standards. The decision stems from safety concerns, including potential liver toxicity and neurotoxic effects associated with the leaves, which have not been adequately studied or approved under food safety regulations. Health experts stress that this advisory should not alarm consumers, as ashwagandha root remains safe when used appropriately. They advise consumers to carefully check ingredient labels to ensure that products contain only root-derived extracts. This advisory reflects a broader regulatory effort to ensure clarity and safety in India’s rapidly growing wellness market, reminding users that natural products can carry risks if not used correctly.